AI heart scan study aims to sharpen artery treatment
NCT ID NCT06376851
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study collects data from 20,000 people with coronary artery disease to see if an AI tool (HeartFlow AI-QCPA) helps doctors make better treatment decisions compared to standard CT scans alone. Participants are stable adults who have had a heart CT or stress test. The study does not test a new drug or device, but observes how AI changes medical management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Moses Cone Memorial Hospital
Greensboro, North Carolina, 27401, United States
Conditions
Explore the condition pages connected to this study.